Moderna (MRNA)

SBC to Revenue

82.76%

Quarterly · Period ending:

MRNA logo

MRNA SBC to Revenue

Latest reported82.76%
MRNA Quarterly SBC/Revenue (26.12% → 82.76%)
High-resolution chart · PNG

MRNA sbc to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Moderna SBC to Revenue — Quarterly
Period endingSBC to Revenue
82.7586%
26.7352%
0%
12.3031%
91.5493%
107.4766%
10.8787%
6.0377%
50.6787%
60.479%
2.8084%
4.2054%
21.5116%
4.0805%
1.2041%
2.1739%
1.0951%
0.7407%
0.5325%
0.8283%
0.8304%
1.7212%
4.4642%
14.6957%
37.6784%
238.4074%
144.6176%
122.0462%
164.2972%
115.4259%
89.3284%
35.2516%
49.7487%
40.8106%
11.9995%
24.4037%
26.1197%
26.1197%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.